NewLimit is a biotechnology company working to radically extend human healthspan. We’re developing medicines to treat age-related diseases by reprogramming the epigenome, a new therapeutic mechanism to restore regenerative potential in aged and diseased cells. We leverage functional genomics, pooled perturbation screening, and machine learning models to unravel the biology of epigenetic aging and disease using experiments of unprecedented scale.
NewLimit is recruiting a Machine Learning Group Leader to lead our Predictive Modeling team. Our team is developing models to predict the effect of epigenetic reprogramming perturbations on cell state & function in silico, powered by the world’s largest data corpus of reprogramming experiments. These models are an essential component of our Discovery Engine, allowing us to search efficiently through the massive space of epigenetic reprogramming hypotheses.
Your role will focus on improving these models & developing new methods to accelerate the pace of NewLimit’s therapeutic discoveries.
As the Group Leader of our Predictive Modeling team, you will:
NewLimit offers generous benefits to ensure our team can focus on our mission:
Compensation for the role will depend on a number of factors, including a candidate’s qualifications, skills, competencies, and experience. Learn more at: https://www.newlimit.com/careers *This compensation and benefits information is based on Company's good faith estimate as of the date of publication and may be modified in the future.